News & Blog
News & Blog
Webinar Recording: Lexeo Therapeutics May 2025 Update
Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2
Gehr Family shares their FA journey, how they raise awareness of Friedreich’s ataxia, and the upcoming Cure FA Soirée with local media outlets
Meet the Community: Alyssa Hammers
Meet the Community: Christi Wilson
Meet the Community: Talia Cassel
Participating in Research: Marc and Maggie Likins
Community Statement: Biogen announces BRAVE Phase 3 Pediatric Study of Omaveloxolone
Meet the Community: Natalie Rex
April/May 2025 – Advocacy Newsletter
